BSX R&D to Revenue
Boston Scientific · R&D to Revenue
BSX R&D to Revenue
Latest reported10.18%period ending
BSX Quarterly R&D/Revenue (0.00% → 10.18%)
Latest values, visible window
High-resolution chart · PNG
BSX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10.1801% | |
| 9.9174% | |
| 10.7643% | |
| 10.1481% | |
| 10.3932% | |
| 9.5003% | |
| 10.0855% | |
| 9.6698% | |
| 9.2961% | |
| 9.4917% | |
| 9.745% | |
| 10.0936% | |
| 9.975% | |
| 9.9439% | |
| 10.1789% | |
| 10.694% | |
| 10.3268% | |
| 10.542% | |
| 10.2335% | |
| 10.573% | |
| 9.6848% | |
| 10.0291% | |
| 10.5613% | |
| 11.8466% | |
| 12.0819% | |
| 11.7971% | |
| 10.6368% | |
| 11.304% | |
| 10.6423% | |
| 11.2314% | |
| 11.2456% | |
| 12.0769% | |
| 11.0442% | |
| 10.971% | |
| 10.9635% | |
| 11.4311% | |
| 10.8108% | |
| 10.8796% | |
| 11.6842% | |
| 11.0214% | |
| 10.4421% | |
| 10.6925% | |
| 12.3357% | |
| 11.7055% | |
| 11.9371% | |
| 10.8597% | |
| 11.0228% | |
| 11.4843% | |
| 10.9984% | |
| 10.7666% | |
| 11.7519% | |
| 12.5072% | |
| 12.3273% | |
| 11.5843% | |
| 13.1247% | |
| 12.6801% | |
| 11.6521% | |
| 11.522% | |
| 12.4459% | |
| 12.2199% | |
| 11.2911% | |
| 11.013% | |
| 11.2388% | |
| 12.0042% | |
| 12.0332% | |
| 12.9082% | |
| 11.5921% | |
| 12.7407% | |
| 12.6808% | |
| 12.7861% | |
| 12.8372% | |
| 12.7401% | |
| 12.5% | |
| 11.9257% | |
| 11.8904% | |
| 13.2324% | |
| 13.2786% | |
| 14.094% | |
| 12.9298% | |
| 13.4255% | |
| 13.4123% | |
| 11.4815% | |
| 11.2987% | |
| 11.9788% | |
| 10.2659% | |
| 9.8452% | |
| 9.875% | |
| 9.7841% | |
| 9.0411% | |
| 12.3845% | |
| 13.6315% | |
| 12.8995% | |
| 12.6464% | |
| 12.7633% | |
| 11.6708% | |
| 12.0499% | |
| 12.0056% | |
| 11.2593% | |
| -29.6898% | |
| 12.2388% |